HT-0712 vs. Placebo in Subjects With Age-Associated Memory Impairment (AAMI)
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2 randomized, multicenter, double-blind, placebo-controlled, parallel-group
study to evaluate the efficacy of HT-0712 in improving memory and cognitive performance in
subjects with Age-Associated Memory Impairment (AAMI)